Syndicate content

HIV/AIDS

Weekly Wire: The Global Forum

Roxanne Bauer's picture
These are some of the views and reports relevant to our readers that caught our attention this week.

BBC Media Action’s governance research: emerging evidence and learning
BBC Media Action
Supported by a five-year grant from the UK Department for International Development to achieve governance outcomes in countries across Africa, Asia and the Middle East, this working paper shares the learning and insights our research generates as it progresses. The paper is designed to share some of the most interesting qualitative and quantitative data we have gathered at this relatively early stage in the research. It also explores the conclusions we are beginning to reach about the contexts in which we work and the impact of BBC Media Action’s programmes. Finally, it highlights what our research is, and is not, telling us.
 
The Bad News About the News
Brookings
1998, Ralph Terkowitz, a vice president of The Washington Post Co., got to know Sergey Brin and Larry Page, two young Silicon Valley entrepreneurs who were looking for backers. Terkowitz remembers paying a visit to the garage where they were working and keeping his car and driver waiting outside while he had a meeting with them about the idea that eventually became Google. An early investment in Google might have transformed the Post's financial condition, which became dire a dozen years later, by which time Google was a multi-billion dollar company. But nothing happened. “We kicked it around,” Terkowitz recalled, but the then-fat Post Co. had other irons in other fires. 
 

Social Marketing Master Class: Market Facilitation

Roxanne Bauer's picture
How can a development program work with other actors in a market to provide a product or service? How can we segment a market or use subsidy more effectively?

Social marketing asks questions like these to determine what types of media to use, how to allocate resources, and what the mix and schedule of marketing strategies should be in order to influence how individuals interact with and respond to products and services. It seeks to inform the delivery of competition-sensitive and segmented social change programs.

Rebecca Firestone, a social epidemiologist at PSI with area specialties in sexual and reproductive health and non-communicable diseases, speaks to us about the importance of designing programs that do not just operate in a market but which actively facilitate the market. Ultimately, she says, the goal is to ensure "equitable access to products and services that are going to help people lead healthier lives."

In Myanmar, where the economy is opening up, PSI is working to ensure that the commercial market for condoms is allowed to grow while also finding avenues to deliver condoms to those people who cannot afford them on their own.
 
Market Facilitation
 

Campaign Art: How Do You Talk about Sex When it is Taboo?

Roxanne Bauer's picture

People, Spaces, Deliberation bloggers present exceptional campaign art from all over the world. These examples are meant to inspire.

How do you inform young people of the importance of safe sex in Ethiopia, where sex is a taboo subject?

Turns out, the answer lies in the dance group, Addis Beza. 

Addis Beza means "to live for others" in Amharic, and members of the group, aged 15-20, use their vibrant moves to open-up discussions about safe sex. The group regularly performs in front of mobile HIV testing vans and public spaces, encouraging the crowds they draw to practice safe sex with condoms and to get tested free of charge.

Addis Beza

I Set a Target. I Failed. I’m Still Setting Them.

Jim Yong Kim's picture



I’m a big believer in setting highly ambitious targets in order to galvanize communities and countries to take action on serious issues. When I was at the World Health Organization in 2003, we set a target called “3 x 5” – committing to treat 3 million people with HIV/AIDS in the developing world by 2005.

At the time, just a few hundred thousand people in the developing world had access to the life-saving treatment. When we announced the target, the global health community was still arguing about whether HIV treatment in poor countries was possible. Some called it an impossible dream that would give people false hope.

I responded that no one ever said treating 3 million people would be easy. But we needed a measurable and time-limited target to change fundamentally the way we thought about the challenges of HIV in developing countries. The target helped change the way we worked – we had fewer arguments about if we should do it, and focused on how to get it done.


Pages